Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D
Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Zerifin, Israel.
Eur J Gynaecol Oncol. 2002;23(4):300-4.
The aim of this study was to investigate the clinicopathologic features and the outcome in patients with pure and mixed type uterine papillary serous carcinoma (UPSC), and to compare these parameters with those observed in patients with moderately and poorly differentiated endometrioid endometrial carcinoma (MPD-EEC).
The charts of 34 patients with UPSC and 30 patients with MPD-EEC, operated on between January 1995 and December 2000, were retrospectively reviewed. The UPSC group included ten cases of pure and 24 cases of mixed type UPSC (admixed with endometrioid component). All patients had undergone full surgical staging. Clinical features, surgicopathological findings, recurrence rate and recurrence-free interval were compared between the study groups.
Significantly more patients with MPD-EEC than with UPSC were operated on in FIGO stage I and II (p = 0.001). MPD-EEC patients were significantly older and more obese (p = 0.03 and p = 0.01, respectively) as compared with the UPSC patients. Significantly more patients with MPD-EEC presented with postmenopausal bleeding (p = 0.02), had a second primary cancer in the past (p = 0.03) and had a first degree relative with history of malignant disease (p = 0.0001). Conversely, the rates of positive abdominal cytology and cervical involvement were significantly higher in the group of UPSC (p = 0.02 and p = 0.02, respectively). Significantly more patients with UPSC were treated with adjuvant therapy (p = 0.01). No significant difference between the two study groups was observed comparing the recurrence rate, the recurrence free interval and the 3-year survival. There was also no significant difference between the pure and the mixed type UPSC, considering the clinical features and the follow-up data.
The current study presented no significant difference in the outcome of MPD-EEC as compared with the pure and the mixed type UPSC, yet prospective studies are needed to evaluate the role of adjuvant therapy in each study group.
本研究旨在调查纯型和混合型子宫乳头状浆液性癌(UPSC)患者的临床病理特征及预后,并将这些参数与中分化和低分化子宫内膜样腺癌(MPD-EEC)患者的参数进行比较。
回顾性分析1995年1月至2000年12月期间接受手术治疗的34例UPSC患者和30例MPD-EEC患者的病历。UPSC组包括10例纯型和24例混合型UPSC(与子宫内膜样成分混合)。所有患者均接受了全面的手术分期。比较研究组之间的临床特征、手术病理结果、复发率和无复发生存期。
FIGO I期和II期接受手术治疗的MPD-EEC患者明显多于UPSC患者(p = 0.001)。与UPSC患者相比,MPD-EEC患者年龄明显更大且更肥胖(分别为p = 0.03和p = 0.01)。MPD-EEC患者出现绝经后出血的明显更多(p = 0.02),过去有第二原发性癌症的更多(p = 0.03),且有恶性疾病病史的一级亲属的更多(p = 0.0001)。相反,UPSC组的腹腔细胞学阳性率和宫颈受累率明显更高(分别为p = 0.02和p = 0.02)。接受辅助治疗的UPSC患者明显更多(p = 0.01)。比较复发率、无复发生存期和3年生存率时,两个研究组之间未观察到显著差异。考虑到临床特征和随访数据,纯型和混合型UPSC之间也没有显著差异。
本研究显示,与纯型和混合型UPSC相比,MPD-EEC的预后无显著差异,但需要前瞻性研究来评估辅助治疗在每个研究组中的作用。